New supplement aims to boost nutrition in kids with food allergies
NCT ID NCT06751810
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new supplement in 30 children with food allergies who were already avoiding certain foods. The goal was to see if the supplement could improve their growth, vitamin D and DHA levels, and immune system balance. The supplement is not a cure but aims to help children get the nutrients they miss from their restricted diets.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
36 to 60 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * subjects with food allergy * Gestational age ≥ 37 weeks * Stable clinical condition and free from any symptoms possibly related to food allergy at least four weeks prior to study enrollment * Observing a strict cow's milk elimination diet for at least 4 weeks prior to study enrollment and until the completion of the study * Parent(s) or legal guardian agrees not to enroll infant or child in another interventional clinical study while participating in this study * Written informed consent obtained from at least one parent (or legally acceptable representative \[LAR\], if applicable) * Infant or child's parent(s) / LAR is of legal age of majority, must have parental authority, must understand the informed consent form and other study documents, and are willing and able to fulfill the requirements of the study protocol Exclusion Criteria: * other concomitant diseases * Infant or child's parent has other medical or psychiatric condition that, in the judgement of the Investigator, would make the infant or child inappropriate for entry into the study. * Currently participating or having participated in another interventional clinical study within 4 weeks prior to enrollment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Food allergies are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Traslational Medical Science - University of Naples Federico II
Naples, Naples, 80131, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.